There was a clear trend towards increasing EBV seroprevalence with age up to the age of 24 years ( Figure 3 ), particularly when studies with <100 participants (n = 5) were excluded.
← all excerpts
Predictors of Epstein-Barr virus serostatus and implications for vaccine policy: A systematic review of the literature.
1
—
—